Medication Monitor



SORT BY:      Most Recent      Most Viewed     
List-View      Table-View
Generic Name (Trade Name—Company)
Notes
  • October 25, 2018

    Sprayology is voluntarily recalling all lots within expiry from 10/18 to 7/22 of its aqueous-based homeopathic product line because of possible microbial contamination.

    Administration or use of drug products with microbial contamination could result in increased infections that may require medical intervention or be life threatening to certain individuals.

    The products are for assorted symptom relief and can be identified by the main label on the bottle and by the expiration date printed on the backside of the label. Each recalled product is an individual 1.38-oz. oral spray in white bottle manufactured at the King Bio facility in Asheville, NC. The product was distributed nationwide via wholesale, retail, and online sales.

    View the list of recalled products here. 

  • October 25, 2018

    Endo Pharmaceuticals is voluntarily recalling two lots of methocarbamol (Robaxin) 750-mg tablets in 100-count bottle pack. The product labels contain incorrect daily dosing information, misstating the daily dose as "two to four tablets four times daily" rather than the correct dosage of "two tablets three times daily."

    Patients who follow the label directions may experience significant drowsiness or dizziness that would put them at risk of falls or an overdose that could result in seizures, coma, or death. 

    The product is indicated as an adjunct therapy to rest, physical therapy, and other measures to relieve the discomfort associated with acute, painful musculoskeletal conditions. 

    The recall includes the product lot 216702P1, expiration date September 2020; and lot 220409P1, expiration date January 2021.

    To date, Endo Pharmaceuticals has not received any reports of adverse events related to this recall.

  • October 4, 2018

    BioLyte Laboratories is voluntarily recalling lot numbers 1138, 1139, 1146, and 1160 of NeoRelief for Muscle Cramping and Restlessness Topical Gel to the retail and consumer level.

    King Bio Inc., a manufacturer of some of the active ingredients in this product, has been found to have some water contamination issues that could have affected this product. King Bio has issued a recall of these active ingredients in BioLyte’s lot specific product. 

    Administration or use of drug products with microbial contamination could result in increased infections that may require medical intervention or that could be life threatening to certain individuals.

    Lot Number Expiry UPC Size Package type
    1138 1/31/2020 358368002021 2 oz white airless pump bottle
    1139 1/31/2020 358368002021 2 oz white airless pump bottle
    1146 3/29/2020 358368002045 4 ml 4” x 2” mylar foil pack
    1160 10/10/2019 358368002021 2 oz white airless pump bottle

    BioLyte Laboratories is notifying its retail partners, distributors, and customers by letter and is arranging for return and replacement of the recalled product.

    To date, there have been no reports of illness or injury due to use of this product.

  • September 12, 2018

    Pharm D Solutions is voluntarily recalling all sterile compounded drug products dispensed with the past 12 months because of concerns that practices at the pharmacy may pose a risk of contamination to products intended to be sterile. These concerns arose following a routine inspection of the pharmacy by FDA.

    Administration of a nonsterile product that is intended to be sterile by S.C., I.M., I.V., or ocular routes of administration may result in serious injury or death.

    Pharm D Solutions stated that to date, it is not aware of any adverse events related to this recall nor any indication that the compounded sterile drug products being recalled are actually contaminated. No medications or any component thereof have been shown to be nonsterile.

    The recall encompasses all compounded sterile drug products, within expiry, that were dispensed within the last twelve months. The sterile drug products subject to this recall were distributed nationwide and directly to customers and/or medical facilities. The recall does not affect the pharmacy’s nonsterile compounded products or retail pharmacy operations.

  • September 12, 2018

    FDA is alerting consumers and health professionals to a voluntary recall of all water- and alcohol-based Beaumont Bio Med Inc. (Grand Rapids, MI) drug products. These products, labeled as homeopathic, are being recalled due to microbial contamination at the manufacturing facility. 

    Administration or use of drug products with microbial contamination could result in increased infections that may require medical intervention or be life-threatening to certain individuals.

    These products were manufactured at the King Bio, Inc., facility in Asheville, NC. Previously, FDA alerted consumers to HelloLife’s voluntary recall of drug products labeled as homeopathic, also manufactured by King Bio.

Pages